Ricardo Ruiz-Villaverde

161PUBLICATIONS
135CO-AUTHORS
NeonatologyNanotoxicology, health and safetyAllergyMajor global burdens of diseaseImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (161)

|Jun 22, 2026
ACOX1 Gain-of-Function and De Novo ROBO1 Variant in ACOX1-sEDD.

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|May 27, 2026
Efficacy and Safety of Guselkumab in Real-World Evidence: A Systematic Review and Meta-Analysis.

|Apr 14, 2026
Mogamulizumab-Induced Linear IgA Bullous Dermatosis in a Patient With Sézary Syndrome.

María Zulaika-Lloret, David Moyano-Bueno, Ricardo Ruiz-Villaverde

|Mar 31, 2026
Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Joan Ceravalls, Ignasi Figueras-Nart, Javier Melgosa Ramos

|Mar 14, 2026
Ixekizumab optimization in moderate-to-severe plaque psoriasis in real clinical practice: a retrospective multicenter study.

Joan Ceravalls, Rosa Fornons, Maribel Iglesias-Sancho

Pageof 27

Frequent Collaborators

50 joint publications

Francisco Navarro-Triviño

21 joint publications

Álvaro Prados-Carmona

12 joint publications

Teresa Rodenas-Herranz

10 joint publications

José-Juan Pereyra-Rodriguez